Complete wound closure following a single topical application of a novel autologous homologous skin construct: first evaluation in an open‐label , single‐arm feasibility study in diabetic foot ulcers
Autor: | Robert D. Galiano, David G. Armstrong, Paul M. Glat, Marissa J Carter, Dennis P. Orgill, William W. Li, Charles M. Zelen |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Pilot Projects Dermatology Controlled studies 030207 dermatology & venereal diseases 03 medical and health sciences autologous homologous skin construct 0302 clinical medicine novel therapy Diabetes Mellitus medicine Humans Prospective Studies 030212 general & internal medicine Adverse effect Wound Healing business.industry Single application Original Articles medicine.disease Diabetic foot Diabetic Foot Surgery Diabetic foot ulcer Feasibility Studies Original Article Wound closure Open label Wound healing business diabetic foot ulcer |
Zdroj: | International Wound Journal |
ISSN: | 1742-481X 1742-4801 |
DOI: | 10.1111/iwj.13404 |
Popis: | Diabetic foot ulcers (DFUs) are a growing burden on patients and health care systems that often require multiple treatments of both conventional and advanced modalities to achieve complete wound closure. A novel autologous homologous skin construct (AHSC) has been developed to treat cutaneous defects with a single topical application, by leveraging the endogenous repair capabilities of the patient's healthy skin. The AHSC's ability to close DFUs with a single treatment was evaluated in an open‐label, single‐arm feasibility study. Eleven patients with DFUs extending up to tendon, bone, or capsule received a single topical application of AHSC. Closure was documented weekly with high‐resolution digital photography and wound planimetry. All 11 DFUs demonstrated successful graft take. Ten DFUs closed within 8 weeks. The median time‐to‐complete closure was 25 days. The mean percent area reduction for all 11 wounds at 4 weeks was 83%. There were no adverse events related to the AHSC treatment site. This pilot study demonstrated AHSC may be a viable single application topical intervention for DFUs and warrants investigation in larger, controlled studies. |
Databáze: | OpenAIRE |
Externí odkaz: |